Open Orphan pushes ahead with hVIVO COVID Clear, the ‘most accurate’ antibody test

165 Aufrufe

  • Danke für die Bewertung! Teile es mit Deinen Freunden!

    Danke für Deine Bewertung!

admin
Published
Subscribe ► https://www.youtube.com/IGUnitedKingdom?sub_confirmation=1

Open Orphan updates investors on the progress it’s making in its target of testing 3,000 people a day, pushing to 6,000, to confirm Covid-19 antibodies. It’s test is for corporations only.

Learn more about IG: https://www.ig.com?CHID=9&SM=YT
Twitter: https://twitter.com/IGcom
Facebook: https://www.facebook.com/IGcom
LinkedIn: https://www.linkedin.com/company/igcom
#antibodytesting #COVID #economicmarkets


We provide fast and flexible access to over 16,000 financial markets – including indices, shares, forex and commodities – through our award-winning range of platforms and apps.

Established in 1974 as the world’s first financial spread betting firm, we’re now the world’s No.1 provider of CFDs and spread betting* and a global leader in forex. We also offer an execution-only share dealing service in the UK, Ireland, Germany, Austria and the Netherlands. Our range of affordable, fully managed investment portfolios rounds out our comprehensive offering to investors and active traders.

Through our low fees and smart price-sourcing technology, we help traders keep their costs down.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading spread bets and CFDs with this provider†. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money. Professional clients can lose more than they deposit.

* Based on revenue excluding FX (published financial statements, February 2018).

† For the 12 months preceding 1 April 2020.
Kategorien
Corona Virus aktuelle Videos
Kommentare deaktiviert.

Als nächstes

Яндекс.Метрика Top.Mail.Ru